Skip to main navigation Skip to search Skip to main content

How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease? Commentary

  • Imperial College Healthcare NHS Trust

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish
Pages (from-to)540-541
Number of pages2
JournalNature Clinical Practice Gastroenterology and Hepatology
Volume3
Issue number10
DOIs
Publication statusPublished - Oct 2006
Externally publishedYes

Cite this